Assignee
SHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD
CN·0 granted patents·5 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
5 records- 0159US2025049849A1Product and method for treating thrombocytopeniaSHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0257US2025090523A1Pharmaceutical composition or drug kit for alleviating or treating fibrotic diseases, and use thereofSHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0355US2024327510A1Drug for preventing, alleviating or treating mucosal adhesion and use thereofSHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0453US2025011719A1New method for improving quality of plateletsSHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0551US2024294668A1Novel antithrombotic antibodySHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI SYNVIDA BIOTECHNOLOGY CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →